J. Moreira

发表

Molecular characterization of apocrine carcinoma of the breast: Validation of an apocrine protein signature in a well‐defined cohort

Takuji Iwase, Futoshi Akiyama, F. Akiyama, 2009, Molecular oncology.

Tumor interstitial fluid - a treasure trove of cancer biomarkers.

I. Gromova, P. Gromov, J. Moreira, 2013, Biochimica et biophysica acta.

Proteomic analysis of tissue samples in translational breast cancer research

I. Gromova, P. Gromov, J. Moreira, 2014, Expert review of proteomics.

Up‐regulated Proteins in the Fluid Bathing the Tumour Cell Microenvironment as Potential Serological Markers for Early Detection of Cancer of the Breast

J. Bunkenborg, P. Roepstorff, I. Gromova, 2010, Molecular oncology.

Identification of BLCAP as a novel STAT3 interaction partner in bladder cancer

I. Gromova, P. Gromov, J. Moreira, 2017, PloS one.

TIMP-1 increases expression and phosphorylation of proteins associated with drug resistance in breast cancer cells.

Dorte B. Bekker-Jensen, J. Stenvang, N. Brünner, 2013, Journal of proteome research.

CIP2A oncoprotein controls cell growth and autophagy through mTORC1 activation

P. Kohonen, M. Jäättelä, P. Puustinen, 2014, The Journal of cell biology.

Down-regulation of the Tumor Suppressor Protein 14-3-3σ Is a Sporadic Event in Cancer of the Breast

J. Celis, G. Ohlsson, F. Rank, 2005, Molecular & Cellular Proteomics.

Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab

H. Nielsen, N. Brünner, I. Christensen, 2015, International journal of cancer.

A streamlined mass spectrometry–based proteomics workflow for large‐scale FFPE tissue analysis

M. Mann, E. Lengyel, J. Lindebjerg, 2020, The Journal of pathology.

Syddansk Universitet The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells

R. L. Nielsen, Huanming Yang, J. Stenvang, 2016 .

The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells

R. L. Nielsen, Huanming Yang, J. Stenvang, 2016, BMC Genomics.

Itraconazole Reverts ABCB1-Mediated Docetaxel Resistance in Prostate Cancer

T. Kallunki, K. Brasso, F. Jørgensen, 2022, Frontiers in Pharmacology.

Proteomic analysis of urinary fibrinogen degradation products in patients with urothelial carcinomas

I. Gromova, J. Celis, P. Gromov, 2006, Clinical Proteomics.

The net acid extruders NHE1, NBCn1 and MCT4 promote mammary tumor growth through distinct but overlapping mechanisms

S. Pedersen, M. Kveiborg, Jacob Samsøe-Petersen, 2018, International journal of cancer.

Release of transcriptional repression via ErbB2-induced, SUMO-directed phosphorylation of myeloid zinc finger-1 serine 27 activates lysosome redistribution and invasion

E. Papaleo, M. Varjosalo, I. Gromova, 2019, Oncogene.

Biomarker-Guided Repurposing of Chemotherapeutic Drugs for Cancer Therapy: A Novel Strategy in Drug Development

Nils Brünner, Dorte Nielsen, J. Stenvang, 2013, Front. Oncol..

CIP 2 A oncoprotein controls cell growth and autophagy through mTORC 1 activation

P. Kohonen, M. Jäättelä, P. Puustinen, 2014 .

The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses

P. Scheipers, J. Moreira, Poul Sørensen, 2003, BMC Cancer.

The histone deacetylase inhibitor Trichostatin A modulates CD 4 + T cell responses

P. Scheipers, J. Moreira, Poul Sørensen, 2003 .

A streamlined mass spectrometry-based proteomics workflow for large scale FFPE tissue analysis

Matthias Mann, M. Mann, E. Lengyel, 2019, bioRxiv.

Identification of Extracellular and Intracellular Signaling Components of the Mammary Adipose Tissue and Its Interstitial Fluid in High Risk Breast Cancer Patients

I. Gromova, J. Celis, P. Gromov, 2005, Molecular & Cellular Proteomics.

Integrating Proteomic and Functional Genomic Technologies in Discovery-driven Translational Breast Cancer Research*

Lars Bolund, Jiri Bartek, Peter Roepstorff, 2003, Molecular & Cellular Proteomics.

Molecular pathology of breast apocrine carcinomas: A protein expression signature specific for benign apocrine metaplasia

I. Gromova, P. Gromov, F. Rank, 2006, FEBS letters.

Loss of Expression of the Adipocyte-type Fatty Acid-binding Protein (A-FABP) Is Associated with Progression of Human Urothelial Carcinomas*

G. Sauter, J. Celis, P. Gromov, 2005, Molecular & Cellular Proteomics.

FABP7 and HMGCS2 Are Novel Protein Markers for Apocrine Differentiation Categorizing Apocrine Carcinoma of the Breast

I. Gromova, N. Kroman, P. Gromov, 2014, PloS one.

Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas

N. Brünner, B. Kristensen, J. Moreira, 2018, BMC Cancer.

Syddansk Universitet Co-expression of TIMP-1 and its cell surface binding partner CD 63 in glioblastomas

N. Brünner, B. Kristensen, J. Moreira, 2018 .

Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer

C. Collins, Yuzhuo Wang, L. Fazli, 2018, Clinical Cancer Research.

Predictive value of combined analysis of pro‐NPY and ERG in localized prostate cancer

K. Brasso, K. D. Berg, M. Røder, 2018, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Nucleosome structure of the yeast CHA1 promoter: analysis of activation‐dependent chromatin remodeling of an RNA‐polymerase‐II‐transcribed gene in TBP and RNA pol II mutants defective in vivo in response to acidic activators

S Holmberg, S. Holmberg, J M Moreira, 1998, The EMBO journal.

Let-7 microRNA controls invasion-promoting lysosomal changes via the oncogenic transcription factor myeloid zinc finger-1

S. Hautaniemi, I. Gromova, R. Louhimo, 2018, Oncogenesis.

Transcriptional repression of the yeast CHA1 gene requires the chromatin‐remodeling complex RSC

S. Holmberg, J. Moreira, 1999, The EMBO journal.

Omics-based Profiling of Carcinoma of the Breast and Matched Regional Lymph Node Metastasis

Jian Li, Lars Bolund, Heng Li, 2022 .

Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance

J. Stenvang, N. Brünner, C. Andersen, 2015, Molecular oncology.

Towards discovery‐driven translational research in breast cancer

P. Guldberg, H. Mouridsen, I. Gromova, 2004, The FEBS journal.

Apocrine Cysts of the Breast

I. Gromova, I. Vejborg, J. Celis, 2006, Molecular & Cellular Proteomics.

Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia

I. Gromova, P. Gromov, F. Rank, 2007, Molecular oncology.

Proteomic Characterization of the Interstitial Fluid Perfusing the Breast Tumor Microenvironment

K. Sandelin, I. Gromova, J. Celis, 2004, Molecular & Cellular Proteomics.

Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts

N. Ambartsumian, J. Moreira, Charlotta J Olsen, 2010, BMC Cancer.

High level PHGDH expression in breast is predominantly associated with keratin 5‐positive cell lineage independently of malignancy

D. Rimm, I. Gromova, P. Gromov, 2015, Molecular oncology.

Proteomic Profiling of Triple-negative Breast Carcinomas in Combination With a Three-tier Orthogonal Technology Approach Identifies Mage-A4 as Potential Therapeutic Target in Estrogen Receptor Negative Breast Cancer*

I. Gromova, J. Celis, N. Kroman, 2012, Molecular & Cellular Proteomics.

Comparative Analysis of Evolutionarily Conserved Motifs of Epidermal Growth Factor Receptor 2 (HER2) Predicts Novel Potential Therapeutic Epitopes

Huanming Yang, N. Brünner, Xu-xu Zheng, 2014, PloS one.

Interactions of ion transporters and channels with cancer cell metabolism and the tumour microenvironment

S. Pedersen, José M A Moreira, J. Moreira, 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer

J. Stenvang, H. Nielsen, C. Andersen, 2019, International journal of molecular sciences.

15-Prostaglandin Dehydrogenase Expression Alone or in Combination with ACSM1 Defines a Subgroup of the Apocrine Molecular Subtype of Breast Carcinoma*S

Karin Jirström, A. Llombart‐Bosch, K. Jirström, 2008, Molecular & Cellular Proteomics.

Tissue proteomics of the human mammary gland: Towards an abridged definition of the molecular phenotypes underlying epithelial normalcy

A. Llombart‐Bosch, I. Gromova, J. Celis, 2010, Molecular oncology.

Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: Relationship between CK15+ progenitor/amplified cells and pre‐malignant lesions and invasive disease

I. Gromova, P. Gromov, F. Rank, 2007, Molecular oncology.

Drug transporters in breast cancer: response to anthracyclines and taxanes

J. Stenvang, N. Brünner, D. Nielsen, 2015, Expert review of anticancer therapy.

ErbB2-driven breast cancer cell invasion depends on a complex signaling network activating myeloid zinc finger-1-dependent cathepsin B expression.

S. Hautaniemi, E. Valo, P. Kohonen, 2012, Molecular cell.

Functional Proteomic Profiling of Triple-Negative Breast Cancer

I. Gromova, E. Santoni-Rugiu, J. van Oostrum, 2021, Cells.

Immunoexpression Analysis and Prognostic Value of BLCAP in Breast Cancer

G. Sauter, R. Simon, I. Gromova, 2012, PloS one.

A Combined Proteome and Ultrastructural Localization Analysis of 14-3-3 Proteins in Transformed Human Amnion (AMA) Cells

Tao Shen, I. Gromova, J. Celis, 2008, Molecular & Cellular Proteomics.

Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways

Huanming Yang, J. Stenvang, N. Brünner, 2015, Tumor Biology.

Bladder Cancer-associated Protein, a Potential Prognostic Biomarker in Human Bladder Cancer*

Ronald Simon, Guido Sauter, Julio E. Celis, 2009, Molecular & Cellular Proteomics.

Proteomic strategies in bladder cancer: From tissue to fluid and back

I. Gromova, P. Gromov, J. Moreira, 2008, Proteomics. Clinical applications.

Impact of proteomics on bladder cancer research.

I. Gromova, J. Celis, P. Gromov, 2004, Pharmacogenomics.

HLA Class II Histocompatibility Antigen γ Chain (CD74) Expression Is Associated with Immune Cell Infiltration and Favorable Outcome in Breast Cancer

M. Talman, J. Moreira, J. Noer, 2021, Cancers.

Molecular Profiling of Docetaxel-Resistant Prostate Cancer Cells Identifies Multiple Mechanisms of Therapeutic Resistance

J. Stenvang, K. Brasso, M. Røder, 2021, Cancers.

Chromatin‐mediated transcriptional regulation by the yeast architectural factors NHP6A and NHP6B

S. Holmberg, J. Moreira, 2000, The EMBO journal.

Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines

J. Stenvang, N. Brünner, Y. Pommier, 2015, BMC Cancer.

Allosteric regulation of AMP-activated protein kinase by adenylate nucleotides and small-molecule drugs.

S. Galic, J. Moreira, J. Oakhill, 2019, Biochemical Society transactions.

A single lysis solution for the analysis of tissue samples by different proteomic technologies

I. Gromova, P. Gromov, F. Rank, 2008, Molecular oncology.

Expression of the Tumor Suppressor Protein 14-3-3σ Is Down-regulated in Invasive Transitional Cell Carcinomas of the Urinary Bladder Undergoing Epithelial-to-Mesenchymal Transition*

J. Celis, P. Gromov, J. Moreira, 2004, Molecular & Cellular Proteomics.

Determination of Antibody Specificity by Western Blotting

J. Celis, P. Gromov, J. Moreira, 2006 .

Purification and characterization of bioactive his6-tagged recombinant human tissue inhibitor of metalloproteinases-1 (TIMP-1) protein expressed at high yields in mammalian cells.

J. Stenvang, N. Brünner, P. Højrup, 2014, Protein expression and purification.

Contribution of Na+,HCO3−‐cotransport to cellular pH control in human breast cancer: A role for the breast cancer susceptibility locus NBCn1 (SLC4A7)

C. Aalkjaer, S. Pedersen, P. Christiansen, 2013, International journal of cancer.

Neither Reb1p nor Poly(dA·dT) Elements Are Responsible for the Highly Specific Chromatin Organization at the ILV1Promoter*

S. Holmberg, J. Moreira, W. Hörz, 2002, The Journal of Biological Chemistry.

Datin, a yeast poly(dA:dT)-binding protein, behaves as an activator of the wild-type ILV1 promoter and interacts synergistically with Reb1p

J. Remacle, S. Holmberg, J. Moreira, 1998, Molecular and General Genetics MGG.

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: A potential novel approach to the treatment of metastatic colorectal cancer

H. Nielsen, N. Brünner, I. Christensen, 2016, Oncotarget.

University of Southern Denmark TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells A potential novel approach to the treatment of metastatic colorectal cancer

H. Nielsen, N. Brünner, I. Christensen, 2016 .

Syddansk Universitet TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells A potential novel approach to the treatment of metastatic colorectal cancer

H. Nielsen, N. Brünner, I. Christensen, 2016 .

Topoisomerase‐1 gene copy aberrations are frequent in patients with breast cancer

J. Stenvang, N. Brünner, I. Christensen, 2015, International journal of cancer.